Supply Chain Intelligence

Scholar Rock Holding Corporation Supply Chain

SRRK supply chain intelligence for Scholar Rock Holding Corporation: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

SRRK ·Last updated 2026-07-30 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

3Suppliers
3Customers
3Debt Items
20Related Chains

Scholar Rock Holding Corporation Suppliers

TickerNameConfidenceEvidence
ADIMAB ADIMAB 80% Under the Adimab Agreement, as amended, we selected a number of biological targets against which Adimab used its proprietary platform technology to discover and/or optimize antibodies
DYN Dyne Therapeutics, Inc. 72% Reciprocal relationship from DYN graph: ces and our business and operations, including clinical trials, could be disrupted by any problems with our significant third-party vendors. We engage a number…
KROS Keros Therapeutics, Inc. 72% Reciprocal relationship from KROS graph: Reciprocal relationship from SRRK graph: Reciprocal relationship from KROS graph: Reciprocal relationship from SRRK graph: Reciprocal relationship from KROS g…

Scholar Rock Holding Corporation Customers

TickerNameConfidenceEvidence
GILEAD GILEAD 90% In connection with the Collaboration Agreement, we received an upfront payment of $50 million and an equity investment of $30 million
DYN Dyne Therapeutics, Inc. 72% Reciprocal relationship from DYN graph: ces and our business and operations, including clinical trials, could be disrupted by any problems with our significant third-party vendors. We engage a number…
KROS Keros Therapeutics, Inc. 72% Reciprocal relationship from KROS graph: nued regulatory review, which may result in significant additional expense and we may be subject to penalties if we fail to comply with regulatory requirement…

Scholar Rock Holding Corporation Debt Obligations

InstrumentDescriptionConfidenceEvidence
SRRK-DEBT-12742 Warrants outstanding: 7614 90% xbrl warrant detail from xbrl 2025-12-31.
SRRK-DEBT-12743 Xbrl Convertible 90% xbrl convertible detail from xbrl 2018-12-31.
SRRK-DEBT Debt stack $205.7M 90% Market cache reports total debt of $205.7M.

Scholar Rock Holding Corporation Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Scholar Rock Holding Corporation.

Scholar Rock Holding Corporation Ownership

HolderNameConfidenceEvidence
SRRK-OWNER-FMR-LLC FMR LLC 90% 13F overlay lists FMR LLC as top holder; 283 tracked holders.

Scholar Rock Holding Corporation Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
DBVTF DBV TECHNOLOGIES 100.00 2
BBIO BridgeBio Pharma, Inc. 100.00 2
BLRX BioLineRx Ltd. 100.00 2
WHWK Whitehawk Therapeutics, Inc. 100.00 2
CTMX CytomX Therapeutics, Inc. 100.00 2
EDIT Editas Medicine, Inc. 100.00 2
CPRX Catalyst Pharmaceuticals, Inc. 100.00 2
BNBX BNB Plus Corp. 100.00 2
CYTOF Altamira Therapeutics Ltd. 100.00 2
BIOA BioAge Labs, Inc. 100.00 2
CYTK Cytokinetics, Incorporated 100.00 2
CBIO Crescent Biopharma, Inc. 100.00 2
ANL Adlai Nortye Ltd. 100.00 2
ALXO ALX Oncology Holdings Inc. 100.00 2
ANRO Alto Neuroscience, Inc. 100.00 2
CCEP Coca-Cola Europacific Partners PLC 100.00 2
DSGN Design Therapeutics, Inc. 100.00 2
PSNL Personalis, Inc. 100.00 2
AZN AstraZeneca PLC 100.00 2
HTGC Hercules Capital, Inc. 100.00 2
View SRRK supply chain intel →

Explore the full interactive supply chain map for Scholar Rock Holding Corporation.

Open SRRK supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map